Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
General Radiation Oncology
Is it safe to administer Lu 177 therapies in patients with epidural disease in the spinal canal?
Related Questions
For gross hematuria from a primary bladder tumor, what palliative radiation regimen would you recommend?
How would you manage incidentally-found prostate cancer on TURP?
How do you manage prostate cancer in patients that cannot swallow pills?
Would you include the entire bladder in the treatment field of a patient with a history of T1 bladder cancer s/p intravesical therapy who is now being planned for chemoradiation for a T3N1 rectal cancer?
How do you incorporate absolute percent pattern 4 (APP4) into your risk stratification, specifically your recommendation for ADT for intermediate prostate cancer?
Is there any way to safely treat patients with mCRPC with 177-Lu PSMA who are on hemodialysis?
Would you offer palliative radiation to a patient with hematuria from squamous metaplasia of the bladder that is not responding to endoscopic therapy?
When treating prostate cancer with moderate hypo-fractionation, what urethral dose constraints do you consider when boosting the dominate intraprostatic lesion?
What duration androgen deprivation do you recommend with salvage pelvic radiotherapy for pelvic node relapse after prostatectomy?
How do you approach rising PSA following radical prostatectomy and early salvage radiation therapy?
